# Sana Biotechnology, Inc. (SANA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SANA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -47.21M | $ -37.67M | $ 75.33M | $ 119.24M |
| 2025 | $ 0 | $ -250.00M | $ -148.23M | $ 78.86M | $ 160.88M |
| 2024 | $ 0 | $ -280.38M | $ -269.69M | $ 94.20M | $ 250.50M |
| 2023 | $ 0 | $ -306.27M | $ -295.85M | $ 104.10M | $ 287.51M |
| 2022 | $ 0 | $ -301.03M | $ -347.34M | $ 108.25M | $ 499.32M |
| 2021 | $ 0 | $ -423.07M | $ -333.91M | $ 110.94M | $ 728.50M |
| 2020 | $ 0 | $ -363.46M | $ -206.19M | $ 71.91M | $ -421.18M |
| 2019 | $ 0 | $ -55.56M | $ -51.02M | $ 47.70M | $ -142.54M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.63 |
| Liabilities / Eq | 2.13 |
| Current Ratio | 1.29 |

## Other views

- [Metrics](https://sponda.capital/en/SANA.md)
- [Charts](https://sponda.capital/en/SANA/charts.md)
- [Compare](https://sponda.capital/en/SANA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.